A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Participants With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Clinical trial NCT02565914 · COMPLETED
Trial details
- NCT number
- NCT02565914
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2019-05-01
- Enrollment
- 1131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.